Compass Inc. Class A Common Stock vs Exelixis Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.42 (market cap $7.31B), while Exelixis Inc. Common Stock trades at $60.73 (market cap $14.62B). The key difference: Exelixis Inc. Common Stock is far larger — about 2× Compass Inc. Class A Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Exelixis Inc. Common Stock for 0 Days on average.
| COMP | EXEL | |
|---|---|---|
Market Cap | $7.31B | $14.62B |
Volume | 15,861,865 | 2,684,957 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $59.13 |
52-Week Low | $6.68 | $34.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.72B | $13.95B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →